Form D · Biotechnology
Illuminare Biotechnologies Inc
Brooklyn, NY · CIK 0001701523
Offering snapshot reported Jun 4, 2026 · SEC filing
- Reported sold
- $3.65M Offering amount: $4M
- Investors reported
- 42 Form D · investor count
- Minimum accepted
- $1.36K Reported outside-investor minimum
- First sale
- May 7, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 4, 2026 | Initial | $3,650,000 | No comparison | 42 | SEC filing |
| Dec 17, 2018 | Initial | $0 | No comparison | 0 | SEC filing |
| Aug 18, 2017 | Initial | $2,373,677 | No comparison | 44 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-586166
No sales commission or finders' fees.
Source: Form D, filed Jun 4, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ezra Angrist | Promoter |
| Oliver Curme | Director |
| Eric Edidin | Director |
| Andrew Fradkin | Promoter |
| Robert Graifman | Director, Promoter |
| Walter Greenblatt | Director, Executive, Promoter |
| Shay Grinfeld | Director, Promoter |
| Brian Longstreet | Director, Executive |
| Sue Yao | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
327 St Marks Avenue
Brooklyn, NY, 11238
Brooklyn, NY, 11238